Professional
Added to YB: 2026-09-09
Pitch date: 2026-09-04
ALC.AX [neutral]
Alcidion Group Limited
Author Info
Company Info
Alcidion Group Limited, together with its subsidiaries, develops and sells digital health software solutions for healthcare organisations in Australia, New Zealand, and the United Kingdom.
Market Cap
AUD 141.1M
Pitch Price
AUD 0.10
Price Target
N/A
Dividend
N/A
EV/EBITDA
19.96
P/E
61.76
EV/Sales
2.35
Sector
Health Care Technology
Category
growth
August 2026 Update - Alcidion Group Limited
ALC.AX (earnings): Alcidion reported solid FY26 growth, with revenue up 27% to $51.6 million and operating cash flow up 19%. A significant upfront payment from the University Hospital of Sussex contract boosted Q4; without that contract win, the company would have missed guidance. The FY27 outlook is fairly positive: contracted revenue already equals 87% of FY26 revenue, suggesting limited additional wins are needed for growth, despite continued lumpiness.
Read full article (1 min)